Risk factors for premature atherosclerosis

European Journal of Vascular and Endovascular Surgery

Volumn 17, Issue 5, 1999, Pages 394-397

  Leijdekkers, V J ^a,b   Vahl, A C ^a   Leenders, J J M ^a   Huijgens, P C ^a   Gans, R O B ^a   Rauwerda, J A ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RED CROSS HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; SMOKING; STATISTICAL ANALYSIS;

EID: 0033134842     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.1998.0775     Document Type: Article

References (31)

1. Hansen ME, Valentine RJ, McIntire DD. Age-related differences in the population of peripheral atherosclerosis: When is atherosclerosis truly premature? Surg. 118:1995;834-839.
2. Levy PJ, Gonzalez MF, Hornung CA. A prospective evaluation of atherosclerotic risk factors and hypercoagulability in young adults with premature lower extremity atherosclerosis. J Vasc Surg. 23:1996;36-45.
3. Harris LM, Peer R, Curl GR. Long term follow up of patients with early atherosclerosis. J Vasc Surg. 23:1996;576-581.
4. Valentine RJ, Kaplan HS, Green R. Lipoprotein (a), homocysteine and hypercoagulable states in young men with premature peripheral atherosclerosis: A prospective controlled analysis. J Vasc Surg. 23:1996;53-63.
5. Berwanger CS, Jeremy JY, Stansby G. Homocysteine and vascular disease. Br J Surg. 82:1995;726-731.
6. Bontempo FA, Hassett AC, Faruki H. The factor V Leiden mutation: Spectrum of thrombotic events and laboratory evaluation. J Vasc Surg. 25:1997;271-275.
7. Ouriel K, Green RM, Deweese JA. Activated protein C resistance: Prevalence and implications in peripheral vascular disease. J Vasc Surg. 23:1996;46-52.
8. Nityanand S, Bergmark C, De Faire U. Antibodies against endothelial cells and cardiolipin in young patients with peripheral atherosclerotic disease. Journal of Internal Medicine. 238:1995;437-443.
9. Mackworth-Young CG, Loizou S, Walport MJ. Primary antiphospholid syndrome: features of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis. 48:1989;362-367.
10. Valentine RJ, Grayburn PA, Vega GL. Lp(a) lipoprotein is an independent discriminating risk factor for premature peripheral atherosclerosis among white men. Arch Intern Med. 154:1994;801-806.
11. Kwiterovich PO. Dyslipoproteinemia and other risk factors for atherosclerosis in children and adolescents. Atherosclerosis. 108:1994;s55-s71.
12. Aronson DC, Ruys Th, van Bockel H. A prospective survey of risk factors in young adults with occlusive disease. Eur J Vasc Surg. 3:1989;227-232.
13. Ray SA, Rowley MR, Loh A. Hypercoagulable states in patients with leg ischemia. Br J Surg. 81:1994;811-814.
14. Eldrup-Jorgensen J, Flanigan DP, Brace L. HyperÍcoagulable states and lower limb ischemia in young adults. J Vasc Surg. 9:1989;334-341.
15. Van der Griend R, Meuwissen OJATh. Hyperhomocysteinemia risk factor for premature atherosclerosis. Ned Tijdschr Geneesk. 138:1994;456-459.
16. Housley E. Antiphospholipid syndrome. Eur J Vasc Endovasc Surg. 10:1995;394-395.
17. Bick RL, Baker WF. Anticardiolipin antibodies and thrombosis. Haematology/Oncology clinics of North America. 6:1992;1287-1299.
18. Shortell CK, Ouriel K, Green RM. Vascular disease in the antiphospholipid syndrome: A comparison with the patient population with atherosclerosis. J Vasc Surg. 15:1992;158-166.
19. Lockshin MD. Answers to the antiphospholipid syndrome? N Engl J Med. 332:1997;1025-1027.
20. Ray SA, Rowley MR, Bevan DH. Hypercoagulable abnormalities and postoperative failure of patients with raised anticardiolipin antibodies and no other disorder. Ann Rheum Dis. 48:1989;362-367.
21. England RJA. Superior mesenteric artery thrombosis in a patient with the antiphospholipid syndrome. Eur J Vasc Endovasc Surg. 10:1995;372-373.
22. Vahl AC. Superior mesenteric artery occlusion and peripheral emboli caused by an aortic ulcer in a young patient with antiphospholipid syndrome. Surgery. 121:1997;588-590.
23. Ray SA, Rowley MR, Bevan DH. Hypercoagulable abnormalities and postoperative failure of arterial reconstruction. Eur J Vasc Endovasc Surg. 13:1997;363-370.
24. Donaldson MC, Weinberg DS, Belkin M. Screening for hypercoagulable states in vascular surgical practice: A preliminary study. J Vasc Surg. 11:1990;825-831.
25. Smith FB, Lee AJ, Fowkes FGR. Variation in cardiovascular risk factors by angiographic site of lower limb atherosclerosis. Eur J Vasc Endovasc Surg. 11:1996;340-346.
26. Foley PWX, Irvine CD, Standen GR. APC resistance Factor V Leiden and peripheral vascular disease. J Cardiovasc Surg. 5:1997;157-160.
27. Asherson RA, Khamashta MA, Ordi-Ross J. The "primary" antiphospholipid syndrome: Major clinical and serological features. Medicine. 68:1989;366-374.
28. Bick RL, Baker WF. The antiphospholipid and thrombosis syndromes. Medical Clinics of North America. 78:1994;667-684.
29. van den Berg M, Boers GH. Homocysteinuria revisited: What about mild hyperhomocysteinaemia? Postgrad Med J. 72:1996;513-518.
30. van den Berg M, Boers GHJ, Franken DG. HyperÍhomocysteinaemia and endothelial dysfunction in young patients and peripheral arterial occlusive disease. Eur J Clin Invest. 25:1995;176-181.
31. 6plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinaemia. J Vasc Surg. 20:1994;933-940.